CRC primary tumour | CD147 | GLUT1 | ||||
---|---|---|---|---|---|---|
n | Positive (%) | p | n | Positive (%) | p | |
MCT1 | ||||||
 Positive | 452 | 157 (34.7 %) | 0.003 | 425 | 126 (29.6 %) | 0.076 |
 Negative | 36 | 4 (11.1 %) |  | 33 | 5 (15.2 %) |  |
MCT4 | ||||||
 Positive | 269 | 100 (37.2 %) | 0.050 | 262 | 90 (34.4 %) | 0.001 |
 Negative | 203 | 58 (28.6 %) |  | 191 | 38 (19.9 %) |  |
CRC lymph node metastasis | Â | |||||
MCT1 | ||||||
 Positive | 31 | 30 (96.8 %) | 0.100 | 28 | 24 (85.7 %) | 0.165 |
 Negative | 66 | 56 (84.8 %) |  | 44 | 31 (70.5 %) |  |
MCT4 | ||||||
 Positive | 56 | 54 (96.4 %) | 0.007 | 46 | 39 (84.8 %) | 0.019 |
 Negative | 39 | 30 (76.9 %) |  | 25 | 15 (60.0 %) |  |
CRC hepatic metastasis | Â | |||||
MCT1 | ||||||
 Positive | 33 | 24 (72.7 %) | 0.097 | 33 | 23 (69.7 %) | 0.002 |
 Negative | 8 | 3 (37.5 %) |  | 9 | 1 (11.1 %) |  |
MCT4 | ||||||
 Positive | 18 | 16 (88.9 %) | 0.019 | 18 | 18 (100 %) | <0.001 |
 Negative | 25 | 13 (52.0 %) |  | 25 | 6 (24.0 %) |  |